BVI Medical

What BVI Medical does

BVI Medical is a private, diversified global surgical ophthalmic business headquartered in Waltham, Massachusetts, owned by TPG Capital, that develops and manufactures intraocular lenses (IOLs), phacoemulsification and vitreoretinal surgical equipment, and a broad consumables portfolio sold across more than 90 countries. The company's purpose-built brand portfolio includes Beaver (knives and blades), Visitec (cannulas), Malosa (single-use instruments), Vitreq (vitreoretinal products), PhysIOL (premium IOLs acquired in 2018), and flagship trifocal lens brand FINEVISION, with over one million FINEVISION implants worldwide and more than 15 years of clinical use. Core proprietary technology platforms include the FINEVISION POD/CoPODize trifocal IOL optics, ISOFOCAL extended-depth-of-focus optics for the SERENITY line, the Abulafia-Koch Torque toric calculator, and capital equipment lines (R-Evolution/R-Evo Smart phaco systems, the new Virtuoso dual-function phaco-vitrectomy platform CE Marked in April 2026, and the Leos FDA-cleared digital endoscopic laser system for minimally invasive glaucoma surgery). Recent regulatory milestones include FINEVISION HP FDA approval (October 2025) and Leos 510(k) clearance (April 2025), with manufacturing concentrated in Belgium (new Liège IOL plant opened 2023), the United Kingdom, Mexico, and China.

BVI generates revenue primarily through direct enterprise field sales of surgical hardware (capital equipment and intraocular lenses) and consumables (knives, cannulas, drapes, surgical dyes, irrigating solutions, retinal gases) to hospitals, ambulatory surgical centers, and ophthalmic surgeons, supplemented by regional distributors (Medical Mix in Iberia, John Bannon in Ireland) and a U.S. government ECAT contract channel via Lovell Government Services. Go-to-market combines a direct sales force of clinical consultants, US and EU Surgical Leadership Councils of KOL surgeons who guide strategy and product development, an educational community platform (EyeXchange Solutions), and major presence at industry congresses (AAO, ESCRS, EURETINA, FloRETINA). Pricing is quote-based and not publicly disclosed. Customer segments are organized horizontally around four procedure areas (cataract, glaucoma, vitreoretinal, and other ophthalmic) and the company's stated focus is on improving surgical efficiency, consistency, and patient outcomes.

The business has been built and scaled through a combination of organic R&D and a sustained acquisition program — Vitreq and Malosa in 2017, PhysIOL in 2018, Benz Research & Development in 2020, and Medical Mix in 2023 — alongside a $1 billion TPG-led strategic capital raise in March 2025 (the largest medtech funding round of 2025) that refinanced existing debt and added new equity to fund expansion. The company employs 1,001–5,000 people across manufacturing and commercial operations, was recognized with four Medical Device Network Excellence Awards in 2025, and appointed former Insulet CEO Jim Hollingshead as President & CEO in January 2026.

Name

BVI Medical

Legal name

BVI Medical, Inc.

Website

https://bvimedical.com

Company type

Private

Founded year

1932

Operating status

Operating

Headcount range

1,001–5,000 employees

Short description

BVI Medical is a private, TPG-owned global manufacturer of surgical ophthalmic devices—including intraocular lenses, phaco and vitreoretinal equipment, and consumables—sold across 90+ countries to ophthalmic surgeons and hospitals for cataract, glaucoma, and retinal procedures.

Ownership category

akta.pro rank

Product category

Ophthalmic Surgical Devices

NAICS

Ophthalmic Goods Manufacturing (339115), Surgical and Medical Instrument Manufacturing (339112), Surgical Appliance and Supplies Manufacturing (339113)

SIC

Ophthalmic Goods (3851), Surgical & Medical Instruments & Apparatus (3841)

akta.pro primary industry

Cataract Surgery Systems & IOLs (Phaco Systems, IOLs, Intraoperative Aberrometry, Viscoelastics) (HLAHAJAH)

akta.pro secondary industries

Vitreoretinal Surgical Devices (Vitrectomy Systems, Endolaser, Illumination, Tamponades) (HLAHAJAJ), Oculoplastics & Lacrimal Surgical Devices (Ptosis/Orbital Tools, DCR/Lacrimal Stents, Facial Implants) (HLAHAJAL)

Keywords

• Ophthalmic surgical devices
• Intraocular lenses
• Cataract surgery equipment
• Vitreoretinal surgical instruments
• Glaucoma surgical devices

Headquarters

HQ city

Waltham

HQ country

United States

HQ region

North America

Offices8 records

Markets served

GTM type

B2B

Offering type

Hardware or Manufacturing

Cost components

Supply Chain, Operations, Personnel, Technology or R&D, Marketing or Sales, Infrastructure

Revenue model

1. Ophthalmic Surgical Devices and Consumables: BVI generates revenue through the sale of ophthalmic surgical devices including intraocular lenses, phaco equipment, surgical instruments, cannulas, drapes, and other consumable products used in cataract, glaucoma, and vitreoretinal surgery procedures.
2. Surgical Equipment: Sale of capital equipment including phaco systems (R-Evolution, R-Evo Smart), vitreoretinal surgical equipment, and the Virtuoso dual-function platform.
3. Intraocular Lenses (IOLs): Revenue from monofocal and premium IOLs including trifocal (FINEVISION HP), toric, and hydrophobic lenses. Includes both hydrophilic and hydrophobic materials.

Pricing tiers

Go-to-market motion3 records

Distribution channels4 records

Marketing channels6 records

Core offering

BVI Medical manufactures, markets, and sells a portfolio of ophthalmic surgical devices for cataract, glaucoma, vitreoretinal, and adjacent ophthalmic procedures, including intraocular lenses (IOLs), phacoemulsification equipment, surgical lasers, single-use instruments, cannulas, knives, surgical dyes, OVDs, irrigation solutions, drapes, and custom procedure packs. Its brands include Beaver, Visitec, Malosa, Vitreq, PhysIOL, and FINEVISION, sold directly to hospitals, ambulatory surgical centers, and ophthalmic surgeons across 90+ countries.

Product overview

BVI Medical is a diversified global surgical ophthalmic company offering a comprehensive portfolio of products spanning four core procedure areas: Cataract, Glaucoma, Vitreoretinal, and Other Ophthalmic procedures. The company's product ecosystem is organized around four main categories: Equipment (phaco systems including R-Evolution, R-Evo Smart E/S), Consumables (cannulas, knives, surgical dyes, fluid control, single-use instruments, drapes, punctal occluders, OVDs, irrigating solutions), Intraocular Lenses (trifocal IOLs including FINEVISION HP family and FINEVISION family; premium monofocal IOLs including ISOPURE and SERENITY lines; standard monofocal IOLs including PODEYE), and Liquids & Gas (surgical dyes, tamponade agents). Key branded sub-portfolios include Beaver (knives/blades), Visitec (cannulas), Malosa (single-use instruments), PhysIOL (premium IOLs), and Vitreq (vitreoretinal products). The company also offers the CustomEyes surgical pack configuration platform and recently launched Leos (glaucoma laser system) and Virtuoso (dual-function phaco-vitrectomy platform). Products are sold across more than 90 countries through direct operations and distribution partners.

Differentiator

Problem solved

Functional benefit

Brands

• Beaver: Surgical knives and blades
• Visitec
• Malosa
• Vitreq
• PhysIOL
• CustomEyes
• FINEVISION
• Leos
• Virtuoso
• SERENITY
• ISOPURE
• IPure
• PODEYE
• EyeXchange Solutions
• BVI Experience Hub
• Beyeonics Vision

Products and services

• FINEVISION HP Trifocal IOL World's first FDA-approved hydrophobic trifocal intraocular lens providing high-quality vision at all distances for cataract surgery patients, featuring proprietary POD platform and CoPODize technology.
• FINEVISION HP Toric IOL Trifocal toric hydrophobic IOL for patients with cataracts and astigmatism, providing correction of corneal astigmatism along with trifocal vision correction.
• FINEVISION Trifocal IOL Trifocal hydrophilic IOL platform offering high quality vision across all distances; one of BVI's flagship products with over one million implants sold worldwide.
• ISOPURE Premium Monofocal IOL Premium monofocal hydrophobic IOL designed for high-quality vision outcomes in standard cataract procedures.
• SERENITY / ISOPURE SERENITY IOL Premium monofocal hydrophobic IOL with ISOFOCAL technology delivering extended range of vision beyond standard monofocal lenses.
• PODEYE Hydrophobic Monofocal IOL Hydrophobic monofocal IOL launched in Japan as part of BVI's expanding IOL portfolio.
• Leos Laser Endoscopy Ophthalmic System FDA 510(k) cleared laser endoscopy ophthalmic system for minimally invasive glaucoma surgery (MIGS); first and only FDA-cleared laser system with advanced digital endoscopic visualization for ab interno intraocular pressure reduction.
• Virtuoso Dual-Function Surgical Platform Next-generation dual-function phaco-vitrectomy surgical platform combining cataract and vitreoretinal surgery capabilities on a single integrated system.
• R-Evolution Phacoemulsification System Advanced phacoemulsification system for cataract surgery with innovative fluidics technology.
• R-Evo Smart E Phacoemulsification System Phacoemulsification equipment designed for efficient cataract surgery with advanced control features.
• R-Evo Smart S Phacoemulsification System Phacoemulsification system offering surgical precision and efficiency for cataract procedures.
• NuVisc Pro Ophthalmic Viscosurgical Device (OVD) High-quality ophthalmic viscosurgical device for cataract procedures, providing protective coating and space maintenance during surgery.
• Aqure / Aqueo Premium Sterile Irrigating Solutions Sterile physiological irrigation solutions for ophthalmic procedures including Aqure BSS and Aqueo Premium enriched saline with glutathione, bicarbonate, and glucose to support intraocular tissue integrity.
• Monoblue Surgical Dyes (SafR, ILM View, Dual View) Surgical dyes including Monoblue SafR for enhanced visualization, Monoblue ILM View for internal limiting membrane visualization, and Monoblue Dual View for multi-application visualization during ophthalmic surgery.
• Beaver Surgical Knives and Blades World-class surgical knives and blades for ophthalmic procedures, including patented safety shield knives protecting against inadvertent damage.
• Visitec Cannulas Wide portfolio of single-use cannulas designed through high-quality processes to meet evolving ophthalmic surgical needs.
• Malosa Single-Use Instruments High-quality single-use instruments including forceps, needle-holders, choppers, manipulators, scissors, speculums, and I-Ring pupil expanders for various ophthalmic procedures.
• Parasol Punctal Occluders Punctal occlusion devices designed for excellent retention to treat dry eye symptoms; available in multiple sizes.
• Visidrape Surgical Drapes and Covers Surgical drapes including full body, half body, mid-size, and mini options with various materials and aperture designs for ophthalmic surgery.
• CustomEyes Surgical Pack Configurator Customized procedure packs and award-winning configurator platform allowing customers to create personalized surgical packs with efficiency and cost savings.
• EyeXchange Solutions Educational Platform Educational platform connecting experienced and emerging surgeons across cataract, glaucoma, and retina specialties for collaboration and technique refinement.

Quantifiable outcome

• Over 1 million FINEVISION IOLs implanted worldwide as of 2023
• +3 more outcomes

Named customers7 records

Segments4 records

Ideal customer profiles2 records

Technology focussed Yes

API detail

Has API

No

API docs

API detail

Core technology

AI maturity

App detail

Feature6 records

Partnerships

Four partnerships are on record, tiered strategic, core and minor.

• New York Eye and Ear Infirmary of Mount SinaistrategicOthers · 14 May 2026First institution in New York City and tri-state area to adopt BVI's Leos FDA-cleared laser endoscopy system for minimally invasive glaucoma surgery.
• AirgascoreChannel Partner/ Reseller/ Distributor · 11 August 2025BVI and Airgas joined forces to improve surgical access and patient outcomes in retinal care by providing ISPAN ophthalmic gases. The partnership leverages BVI's U.S. distribution network to ensure faster, more efficient delivery of retinal gases to surgeons and clinics.
• LMU Klinikum (Munich, Germany)minorOthers · 15 June 2025First patient successfully treated with Virtuoso dual-function surgical platform at LMU Klinikum in December 2025 as part of ongoing pre-market clinical study led by Professor Siegfried Priglinger.
• Beyeonics VisionstrategicStrategic or Co-development Partner · 4 October 2021BVI announced investment and collaboration with Beyeonics Vision to support surgeon-centered digital visualization, improved ergonomics, and real-time guidance in surgical decision-making. The partnership distributes Beyeonics One exoscope system through BVI/Beyeonics Vision.

Scale indicators8 records

Recent moves9 records

Expansion highlights8 records

Direct peers

• Alcon: Alcon is the global leader in ophthalmic surgical devices, directly competing with BVI across cataract (Centurion phaco, PanOptix trifocal IOL), vitreoretinal, and refractive equipment. As the dominant incumbent, it is the most directly comparable peer for BVI's premium IOL and surgical platform strategy.
• Glaukos Corporation: Glaukos is the leading MIGS device company (iStent, iDose), directly competing with BVI's Leos laser endoscopy system for minimally invasive glaucoma surgery share. Both companies target the same ophthalmic surgeon call point with novel interventional glaucoma technologies.
• ZEISS Medical Technology: ZEISS Medical Technology offers premium IOLs (e.g., AT ELANA, CT SPHERIS), ophthalmic surgical microscopes, and phaco systems that directly overlap with BVI's cataract and vitreoretinal portfolios. ZEISS is also a previous employer of BVI's CTO (Mikhail Boukhny) and CCO (Andrew Chang), making it an especially close comparable on talent and product positioning.
• New World Medical: New World Medical develops glaucoma drainage devices and surgical instruments that overlap with BVI's glaucoma and oculoplastics portfolios. It is a focused emerging player competing in the same interventional glaucoma call point as BVI's Leos system.
• STAAR Surgical: STAAR Surgical is a premium IOL specialist (ICL/collamer lens for refractive, EVO family) and competes with BVI in the premium lens segment. STAAR is a smaller, single-product-focused company but addresses the same premium vision-correction surgeon market.
• Hoya Surgical Optics: Hoya Surgical Optics (part of Hoya Corporation) is a focused IOL manufacturer with a global commercial footprint that competes directly with BVI's premium trifocal (FINEVISION), monofocal, and preloaded IOL lines in Europe, Japan, and other key markets.

Emerging players

• Iridex Corporation: Iridex manufactures ophthalmic laser systems for retinal and glaucoma applications, partially overlapping with BVI's vitreoretinal laser probes and Leos laser endoscopy franchise. It is a smaller, publicly traded comparable for the laser portion of BVI's surgical portfolio.
• Heidelberg Engineering: Heidelberg Engineering develops ophthalmic imaging and diagnostic platforms (e.g., Spectralis OCT) used alongside vitreoretinal and glaucoma surgery workflows. While not a direct surgical-device competitor, it serves the same ophthalmic surgeon customers and increasingly intersects with surgical decision-making visualization—a thematic peer for BVI's Beyeonics AR exoscope investment.

Broad incumbents

• Johnson & Johnson Vision: J&J Vision (TECNIS IOL family, CATALYS femto phaco, iDesign refractive suite) competes with BVI across cataract surgery and adjacent ophthalmic surgery segments. As part of a much larger medtech conglomerate, it has deeper R&D resources but the same core customers as BVI.
• Bausch + Lomb: Bausch + Lomb's Surgical division (now BVI Surgical under separate ownership post-IPO) competes head-to-head with BVI in cataract IOLs, phaco equipment, and vitreoretinal instruments. As a broader diversified eye-health player it sets the benchmark BVI must match in global commercial reach and product breadth.

Market position

Strengths2 records

Weaknesses4 records

Competitive moat6 records

Key risks5 records

Key highlights7 records

Customer concentration

• Xx.com/bvimedical
• YouTubeyoutube.com/c/bvimedical
• Facebookfacebook.com/BVIMedical
• LinkedInlinkedin.com/company/bvi-medical
• Instagraminstagram.com/bvimedical

Compliance4 records

Revenue estimate

Valuation estimate

Number of profiles

Profiles6 records

Subsidiaries5 records

Funding overview

Funding rounds1 record

Investors1 record

Funding detail is available on the Subscription and Enterprise plan.Contact sales →

M&A3 records

Investments1 record

M&A and investment is available on the Subscription and Enterprise plan.Contact sales →

Frequently asked questions about BVI Medical